Alpha-Synuclein mRNA Is Not Increased in Sporadic PD and Alpha-Synuclein Accumulation Does Not Block GDNF Signaling in Parkinson's Disease and Disease Models
Mol Ther
.
2017 Oct 4;25(10):2231-2235.
doi: 10.1016/j.ymthe.2017.04.018.
Epub 2017 May 15.
Authors
Xiaomin Su
1
,
D Luke Fischer
2
,
Xin Li
3
,
Krystof Bankiewicz
4
,
Caryl E Sortwell
2
,
Howard J Federoff
5
Affiliations
1
Department of Neuroscience, Georgetown University Medical Center, Washington DC 20057, USA.
2
Translational Science and Molecular Medicine, College of Human Medicine, Michigan State University, Grand Rapids, MI 48824, USA.
3
Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University Medical Center, Washington, DC 20057, USA.
4
Department of Neurosurgery, University of California at San Francisco, San Francisco, CA 94143, USA.
5
Department of Neurology, University of California at Irvine, Irvine, CA 92697, USA. Electronic address:
[email protected]
.
PMID:
28522034
PMCID:
PMC5628770
DOI:
10.1016/j.ymthe.2017.04.018
No abstract available
Publication types
Letter
Comment
MeSH terms
Glial Cell Line-Derived Neurotrophic Factor
Humans
Parkinson Disease*
RNA, Messenger
Substantia Nigra
alpha-Synuclein*
Substances
Glial Cell Line-Derived Neurotrophic Factor
RNA, Messenger
alpha-Synuclein